COM:TRANSCODETHERAPEUTICS

TransCode Therapeutics

Stock

USD

Last Close

0.38

22/11 21:00

Market Cap

5.96M

Beta: -

Volume Today

269.81K

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-607.21K -	-2.34M 286.01%	-6.84M 191.97%	-17.56M 156.67%	-18.55B 105,485.70%
depreciation and amortization			42.47K -	98.61K 132.18%	516.75M 523,951.27%
deferred income tax			876.19K -	890.95K 1.68%
stock based compensation	1.40K -	45.44K 3,152.97%	186.00K 309.29%	395.33K 112.55%	1.04B 262,185.08%
change in working capital	-4.70K -	309.76K 6,685.10%	432.39K 39.59%	1.31M 202.63%	-1.30B 99,145.56%
accounts receivables				-360.23K -
inventory				360.23K -
accounts payables	-54.74K -	191.25K 449.38%	2.29M 1,094.78%	1.84M 19.31%	-1.30B 70,394.33%
other working capital	50.04K -	118.51K 136.84%	-1.85M 1,663.31%	-535.20K 71.11%	1.30B 242,257.99%
other non cash items	102.01K -	1.50M 1,366.23%	39.47K 97.36%	-890.95K 2,357.23%	-1.08B 121,351.55%
net cash provided by operating activities	-508.51K -	-492.97K 3.06%	-5.27M 968.40%	-15.76M 199.28%	-18.07B 114,567.86%
investments in property plant and equipment			-254.82K -	-100.92K 60.40%
acquisitions net			3K -
purchases of investments
sales maturities of investments
other investing activites					-35.61M -
net cash used for investing activites			-251.82K -	-100.92K 59.92%	-35.61M 35,184.73%
debt repayment	-500K -	-1.12M 123.30%
common stock issued			26.34M -	5.99M 77.26%	15.91B 265,542.41%
common stock repurchased
dividends paid
other financing activites	1M -	2.23M 123.30%	-818.55K 136.66%	-5.98M 630.93%
net cash used provided by financing activities	500K -	1.12M 123.30%	25.52M 2,185.37%	5.99K 99.98%	15.91B 265,642,311.09%
effect of forex changes on cash
net change in cash	-8.51K -	623.54K 7,428.93%	20.00M 3,107.12%	-15.86M 179.30%	-2.20B 13,778.78%
cash at beginning of period	212.98K -	204.47K 3.99%	828.02K 304.96%	20.83M 2,415.15%	4.97B 23,756.96%
cash at end of period	204.47K -	828.02K 304.96%	20.83M 2,415.15%	4.97M 76.14%	2.77B 55,603.81%
operating cash flow	-508.51K -	-492.97K 3.06%	-5.27M 968.40%	-15.76M 199.28%	-18.07B 114,567.86%
capital expenditure			-254.82K -	-100.92K 60.40%
free cash flow	-508.51K -	-492.97K 3.06%	-5.52M 1,020.09%	-15.86M 187.29%	-18.07B 113,838.37%

All numbers in USD (except ratios and percentages)